Tokyo, September 23, 2020: Eisai Co., Ltd. announced that it has received a positive opinion from the European Medicines Agency…
New Delhi, January 07, 2019: Eisai Co., Ltd. has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa, (generic…
New Delhi, Febraury 14, 2019: Eisai Co., Ltd. announced today that it has submitted an application to the European Medicines Agency…
As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, February 03, 2019: Eisai Co., Ltd.…
For Adjunctive Treatment of Partial Onset Seizures Tokyo, January 05, 2019: Eisai Co., Ltd. announced that its in-house discovered and…